# Investigational Biomarkers for Neurological Immune-related Adverse Events

> **NCT05969379** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 80 (estimated)

## Conditions studied

- Neurological Disease

## Interventions

- **GENETIC:** Analysis of biomarkers and their correlation with clinical characteristics and outcome

## Key facts

- **NCT ID:** NCT05969379
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05969379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05969379, "Investigational Biomarkers for Neurological Immune-related Adverse Events". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05969379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*